Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
The objective is to analyse the changes in the adipose tissue hystological features and the adipogenesis gene expression and related to inflammation after 48 and 96 weeks after the change from AZT+3TC+ABC (Trizivir®) to a monotherapy treatment with LPV/r (Kaletra®)
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
7 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal